Versant Capital Management, Inc Sage Therapeutics, Inc. Transaction History
Versant Capital Management, Inc
- $578 Million
- Q1 2025
A detailed history of Versant Capital Management, Inc transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 1,485 shares of SAGE stock, worth $11,033. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,485
Previous 236
529.24%
Holding current value
$11,033
Previous $1,000
1100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding SAGE
# of Institutions
194Shares Held
44.9MCall Options Held
304KPut Options Held
117K-
Black Rock Inc. New York, NY5.22MShares$38.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.84MShares$35.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.59MShares$34.1 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.46MShares$33.1 Million0.48% of portfolio
-
Rtw Investments, LP New York, NY3MShares$22.3 Million0.27% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $442M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...